Small biotechs raring to cash in on the orphan disease market.Published in:Nature Medicine, 2012, v. 18, n. 3, p. 330, doi. 10.1038/nm0312-330By:Hersher, RebeccaPublication type:Article
Deal watch: Biogen and Amicus to pursue genetically validated Parkinson's disease target.Published in:Nature Reviews Drug Discovery, 2013, v. 12, n. 11, p. 819, doi. 10.1038/nrd4166By:Flight, Monica HoyosPublication type:Article